Search Results
You are looking at 1 - 3 of 3 items for
- Author: Joyce Emons x
- Refine by access: All content x
Search for other papers by Joyce Emons in
Google Scholar
PubMed
Search for other papers by Andrei S Chagin in
Google Scholar
PubMed
Search for other papers by Torun Malmlöf in
Google Scholar
PubMed
Search for other papers by Magnus Lekman in
Google Scholar
PubMed
Search for other papers by Åsa Tivesten in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Jan M Wit in
Google Scholar
PubMed
Department of Paediatrics, Department of Women's and Children's Health, Division of Endocrinology, Department of Tissue Regeneration, Department of Endocrinology and Metabolism, Leiden University Medical Center, 2300 ZA Leiden, The Netherlands
Search for other papers by Marcel Karperien in
Google Scholar
PubMed
Search for other papers by Lars Sävendahl in
Google Scholar
PubMed
Longitudinal bone growth is regulated in the growth plate. At the end of puberty, growth velocity diminishes and eventually ceases with the fusion of the growth plate through mechanisms that are not yet completely understood. Vascular endothelial growth factor (VEGF) has an important role in angiogenesis, but also in chondrocyte differentiation, chondrocyte survival, and the final stages of endochondral ossification. Estrogens have been shown to up-regulate VEGF expression in the uterus and bone of rats. In this study, we investigated the relation between estrogens and VEGF production in growth plate chondrocytes both in vivo and in vitro. The expression of VEGF protein was down-regulated upon ovariectomy and was restored upon estradiol (E2) supplementation in rat growth plates. In cultured rat chondrocyte cell line RCJ3.1C5.18, E2 dose dependently stimulated 121 and 189 kDa isoforms of VEGF, but not the 164 kDa isoform. Finally, VEGF expression was observed at both protein and mRNA levels in human growth plate specimens. The protein level increased during pubertal development, supporting a link between estrogens and local VEGF production in the growth plate. We conclude that estrogens regulate VEGF expression in the epiphyseal growth plate, although the precise role of VEGF in estrogen-mediated growth plate fusion remains to be clarified.
Search for other papers by Lenneke Schrier in
Google Scholar
PubMed
Search for other papers by Sandra P Ferns in
Google Scholar
PubMed
Search for other papers by Kevin M Barnes in
Google Scholar
PubMed
Search for other papers by Joyce A M Emons in
Google Scholar
PubMed
Search for other papers by Eric I Newman in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
Search for other papers by Jeffrey Baron in
Google Scholar
PubMed
With age, the growth plate undergoes senescent changes that cause linear bone growth to slow and finally cease. Based on previous indirect evidence, we hypothesized that this senescent decline occurs because growth plate stem-like cells, located in the resting zone, have a finite proliferative capacity that is gradually depleted. Consistent with this hypothesis, we found that the proliferation rate in rabbit resting zone chondrocytes (assessed by continuous 5-bromo-2′-deoxy-uridine labeling) decreases with age, as does the number of resting zone chondrocytes per area of growth plate.
Glucocorticoid excess slows growth plate senescence. To explain this effect, we hypothesized that glucocorticoid inhibits resting zone chondrocyte proliferation, thus conserving their proliferative capacity. Consistent with this hypothesis, we found that dexamethasone treatment decreased the proliferation rate of rabbit resting zone chondrocytes and slowed the numerical depletion of these cells. Estrogen is known to accelerate growth plate senescence. However, we found that estradiol cypionate treatment slowed resting zone chondrocyte proliferation.
Our findings support the hypotheses that growth plate senescence is caused by qualitative and quantitative depletion of stem-like cells in the resting zone and that growth-inhibiting conditions, such as glucocorticoid excess, slow senescence by slowing resting zone chondrocyte proliferation and slowing the numerical depletion of these cells, thereby conserving the proliferative capacity of the growth plate. We speculate that estrogen might accelerate senescence by a proliferation-independent mechanism, or by increasing the loss of proliferative capacity per cell cycle.
Search for other papers by Joyce Emons in
Google Scholar
PubMed
Search for other papers by Bas E Dutilh in
Google Scholar
PubMed
Search for other papers by Eva Decker in
Google Scholar
PubMed
Search for other papers by Heide Pirzer in
Google Scholar
PubMed
Search for other papers by Carsten Sticht in
Google Scholar
PubMed
Search for other papers by Norbert Gretz in
Google Scholar
PubMed
Search for other papers by Gudrun Rappold in
Google Scholar
PubMed
Search for other papers by Ewan R Cameron in
Google Scholar
PubMed
Search for other papers by James C Neil in
Google Scholar
PubMed
Search for other papers by Gary S Stein in
Google Scholar
PubMed
Search for other papers by Andre J van Wijnen in
Google Scholar
PubMed
Search for other papers by Jan Maarten Wit in
Google Scholar
PubMed
Search for other papers by Janine N Post in
Google Scholar
PubMed
Search for other papers by Marcel Karperien in
Google Scholar
PubMed
In late puberty, estrogen decelerates bone growth by stimulating growth plate maturation. In this study, we analyzed the mechanism of estrogen action using two pubertal growth plate specimens of one girl at Tanner stage B2 and Tanner stage B3. Histological analysis showed that progression of puberty coincided with characteristic morphological changes: a decrease in total growth plate height (P=0.002), height of the individual zones (P<0.001), and an increase in intercolumnar space (P<0.001). Microarray analysis of the specimens identified 394 genes (72% upregulated and 28% downregulated) that changed with the progression of puberty. Overall changes in gene expression were small (average 1.38-fold upregulated and 1.36-fold downregulated genes). The 394 genes mapped to 13 significantly changing pathways (P<0.05) associated with growth plate maturation (e.g. extracellular matrix, cell cycle, and cell death). We next scanned the upstream promoter regions of the 394 genes for the presence of evolutionarily conserved binding sites for transcription factors implicated in growth plate maturation such as estrogen receptor (ER), androgen receptor, ELK1, STAT5B, cyclic AMP response element (CREB), and RUNX2. High-quality motif sites for RUNX2 (87 genes), ELK1 (43 genes), and STAT5B (31 genes), but not ER, were evolutionarily conserved, indicating their functional relevance across primates. Moreover, we show that some of these sites are direct target genes of these transcription factors as shown by ChIP assays.